1 – 10 of 43
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2024
-
Mark
The anti-leprosy drug clofazimine reduces polyQ toxicity through activation of PPARγ
(
- Contribution to journal › Article
- 2023
-
Mark
Altered Adipocyte Cell Size Distribution Prior to Weight Loss in the R6/2 Model of Huntington's Disease
(
- Contribution to journal › Article
-
Mark
Mechanisms underlying metabolic alterations in Huntington's disease. Beyond the brain and back.
2023) In Lund University, Faculty of Medicine Doctoral Dissertation Series(
- Thesis › Doctoral thesis (compilation)
-
Mark
Effects of mutant huntingtin in oxytocin neurons on non-motor features of Huntington's disease
(
- Contribution to journal › Article
-
Mark
Comorbidities and clinical outcomes in adult- and juvenile-onset Huntington’s disease : a study of linked Swedish National Registries (2002–2019)
(
- Contribution to journal › Article
- 2022
-
Mark
Decreased CSF oxytocin relates to measures of social cognitive impairment in Huntington's disease patients
(
- Contribution to journal › Article
- 2020
-
Mark
No symphony without bassoon and piccolo : Changes in synaptic active zone proteins in Huntington's disease
(
- Contribution to journal › Article
-
Mark
Imbalance of the oxytocin-vasopressin system contributes to the neuropsychiatric phenotype in the BACHD mouse model of Huntington disease
(
- Contribution to journal › Article
-
Mark
Development and Applications of in vitro Models to Study Human Brain Evolution and Disease
2020) In Lund University, Faculty of Medicine Doctoral Dissertation Series(
- Thesis › Doctoral thesis (compilation)
- 2019
-
Mark
Leptin deficiency reverses high metabolic state and weight loss without affecting central pathology in the R6/2 mouse model of Huntington's disease
(
- Contribution to journal › Article